Common blood pressure drug could make cancer therapy far more powerful
2 weeks ago
Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer drug olaparib, potentially expanding its benefits beyond patients with BRCA-related tumors. The combination is already being tested in human clinical trials after showing strong immune-boosting and anticancer effects in preclinical studies.
phone_android📱 Use Epelcon on Your PhoneFaster. Always with you. Install the new Epelcon Mobile App v3.1.0 and access all 19 modules from your Android phone — Wallet, Jobs, Property, Diet Plans, Courses, Blog & more.Get the App
Advertise With Us!
Promote your brand, products or services across our homepage, shop, blog, email newsletters & social media channels.
This website uses cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking “Accept”, you consent to our use of cookies.